The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Recurrence patterns in the prospective, randomized, controlled, multicenter phase III ESOPEC trial comparing perioperative chemotherapy with preoperative chemoradiotherapy in patients with esophageal adenocarcinoma.
 
Jens Hoeppner
No Relationships to Disclose
 
Claudia Schmoor
Consulting or Advisory Role - Novartis
 
Fabian Nimczewski
No Relationships to Disclose
 
Zsolt Madarasz
No Relationships to Disclose
 
Patrick Plum
Travel, Accommodations, Expenses - Servicegesellschaft am Klinikum Ernst von Bergmann mbH
 
Thomas Brunner
Honoraria - AstraZeneca/Merck; Daiichi Sankyo; Merck
Consulting or Advisory Role - Astellas Oncology
Travel, Accommodations, Expenses - Varian Biopharma
 
Florian Lordick
Honoraria - Astellas Pharma; AstraZeneca; BioNTech; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Incyte; Lilly; Merck KGaA; Merck Sharp & Dohme; Roche; SERVIER
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; PAGE; SERVIER
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly
 
ESOPEC Study Group
No Relationships to Disclose